The World Health Organization has established a secretariat on Public Health, Innovation, Essential Health Research and Intellectual Property. This will convene and facilitate an intergovernmental working group, as requested by WHO member states in a resolution at the World Health Assembly in May 2006.
The intergovernmental working group, open to all member states, will develop a global strategy and plan of action, including to provide a framework to enhance R&D into diseases that disproportionately affect developing countries.
The secretariat is currently holding consultations with stakeholders and will convene the first meeting of the intergovernmental working group in early December.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze